| Autor: |
Dmitry I. Trukhan, Victoria V. Goloshubina, Inna A. Viktorova |
| Jazyk: |
English<br />Russian |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Клинический разбор в общей медицине, Vol 3 , Iss 5, Pp 60-67 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2713-2552 |
| DOI: |
10.47407/kr2022.3.5.00164 |
| Popis: |
Diabetes mellitus (DM) is one of the most important comorbidities associated with the severity of all three known pathogenic human coronavirus infections, including the SARS-CoV-2 (COVID-19) virus. The implementation of regular monitoring of plasma glucose is important during a pandemic for patients with type I and type II diabetes. Less studied within the framework of COVID-19 is the problem of developing diabetes after a coronavirus infection. The first part of the review discusses the etiopathogenesis of DM in the post-COVID syndrome and presents clinical observations indicating an increased risk of developing diabetes after SARS-CoV-2 infection, which predetermines the need for glycometabolic control in the post-COVID syndrome. Hyperglycemia is a leading factor in the development of complications of DM. Glycated hemoglobin is the "gold standard" for monitoring glycemic control, but this indicator does not provide complete information about daily and intraday changes in glucose levels. An important place in the prevention of complications in patients with DM, especially during the pandemic of a new coronavirus infection, is occupied by regular self-monitoring of glucose levels. An important aspect of the technical impact on the adherence of patients to self-control and treatment of DM is the availability of convenient communication between the patient and the doctor, in particular, the possibility of contact remotely via a computer and mobile phone. In the second part of the review, the capabilities of the new model of the Contour glucometer line, the Contour Plus One glucometer, are considered. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
